Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. was founded in 2002 and is based in Houston, Texas. Nanospectra Biosciences, Inc., a medical device company, engages in developing and commercializing particle-based therapies for the selective and precise thermal destruction of solid tumors. The company provides AuroLase Therapy, a medical device that is applicable to the ablation of various solid tumors. It also offers research-use-only nanoparticles with specific optical characteristics.
Contact Details
Office Address
Nanospectra Biosciences, Inc.
8285 El Rio Street, Suite 150
Houston, TX, USA 77054
Phone: (713) 842-2720
Fax: (713) 440-9349
Executives
Chairman
David Anderson
President, CEO, and Director
J. Donald Payne